These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18946098)

  • 1. Endometrial thickness dynamics and morphologic characteristics during pituitary downregulation with antagonists in assisted reproductive technology cycles.
    Detti L; Yelian FD; Kruger ML; Diamond MP; Puscheck EE
    J Ultrasound Med; 2008 Nov; 27(11):1591-6. PubMed ID: 18946098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes.
    Kuć P; Kuczyńska A; Topczewska M; Tadejko P; Kuczyński W
    Gynecol Endocrinol; 2011 Nov; 27(11):867-73. PubMed ID: 21231852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial.
    Beguería R; García D; Vassena R; Rodríguez A
    Hum Reprod; 2019 May; 34(5):872-880. PubMed ID: 30927417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration.
    Wu Y; Gao X; Lu X; Xi J; Jiang S; Sun Y; Xi X
    Reprod Biol Endocrinol; 2014 Oct; 12():96. PubMed ID: 25296555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between endometrial thickness and pregnancy rates in GnRH antagonist down-regulated ICSI cycles.
    Kinay T; Tasci Y; Dilbaz S; Cinar O; Demir B; Haberal A
    Gynecol Endocrinol; 2010 Nov; 26(11):833-7. PubMed ID: 20504095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist.
    Detti L; Yelian FD; Kruger ML; Diamond MP; Rode A; Mitwally MF; Puscheck EE
    Fertil Steril; 2008 Apr; 89(4):998-1001. PubMed ID: 17678904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.
    Golbasi H; Ince O; Golbasi C; Ozer M; Demir M; Yilmaz B
    J Obstet Gynaecol; 2019 Feb; 39(2):157-163. PubMed ID: 30280612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial but not Ovarian Response is Associated With Clinical Outcomes and can be Improved by Prolonged Pituitary Downregulation in Patients With Thin and Medium Endometrium.
    Song J; Sun X; Qian K
    Reprod Sci; 2019 Nov; 26(11):1409-1416. PubMed ID: 30501453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
    Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
    Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of endometrial thickness on treatment outcomes following in vitro fertilization/intracytoplasmic sperm injection.
    Ma NZ; Chen L; Dai W; Bu ZQ; Hu LL; Sun YP
    Reprod Biol Endocrinol; 2017 Jan; 15(1):5. PubMed ID: 28056983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?
    Mercé LT; Barco MJ; Bau S; Troyano J
    Fertil Steril; 2008 Jan; 89(1):111-7. PubMed ID: 17555754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
    Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
    J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between pregnancy rates following in vitro fertilization or intracytoplasmic sperm injection and endometrial thickness and pattern.
    Rashidi BH; Sadeghi M; Jafarabadi M; Tehrani Nejad ES
    Eur J Obstet Gynecol Reprod Biol; 2005 Jun; 120(2):179-84. PubMed ID: 15925048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parabolic trend in endometrial thickness at embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cases with clinical pregnancy evidence.
    Lamanna G; Scioscia M; Lorusso F; Serrati G; Selvaggi LE; Depalo R
    Fertil Steril; 2008 Oct; 90(4):1272-4. PubMed ID: 17953948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes.
    Detti L; Ambler DR; Yelian FD; Kruger ML; Diamond MP; Puscheck EE
    J Assist Reprod Genet; 2008 May; 25(5):177-81. PubMed ID: 18461435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.